<DOC>
	<DOC>NCT00439504</DOC>
	<brief_summary>The purpose of this study is to determine if there are significant cardiovascular or other interactions between sublingual lobeline and intravenous methamphetamine.</brief_summary>
	<brief_title>Ph1 Lobeline Interaction Study - 1</brief_title>
	<detailed_description />
	<mesh_term>Lobeline</mesh_term>
	<criteria>Be between the ages of 18 and 45 years of age Be in general good health with a history of methamphetamine (MA) abuse (but not dependence) If female and of child bearing potential, agrees to use birth control Be able to understand and provide written informed consent Have a body mass index between 18 and 30 Have reported use of (MA) during the past three months without experiencing adverse consequence plus a life time MA or amphetamine use history of at least four occasions of use Have a negative drug test (barbiturates, benzodiazepines, amphetamines, opiates, cocaine, cannabinoids, ethanol) at screening and at the time of admission Please contact site for details</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>